4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000002
Chief Commercial Officer sold 2,804 shares at $32.18 ($90,233)
- Chief Commercial Officer acquired 8,476 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/wk-form4_1736287498.xml…